// App-Quantinova.ai

e15136 : Assessing the utility and benefit of granulocyte-colony stimulating factor (G-CSF) in adjuvant therapy for stage III colon cancer.

Researchers

Presenter

  • Vishal Vashistha

Principal Investigators

  • Robert James Pelley

  • Marc A. Shapiro

  • Bassam N. Estfan

Medical Centers

  • Cleveland Clinic Foundation, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Neutropenia

  • Peripheral neuropathy

  • Solid malignancies

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Filgrastim

  • Oxaliplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved